Collaboration to virtually gather patient-reported outcomes for lung cancer

EmpiraMed (MA, USA) and the LUNGevity Foundation (MD, USA) have announced their collaboration on a global study to virtually gather patient-reported outcomes from individuals with lung cancer in real-world settings, providing novel approaches for lung cancer clinical studies. EmpiraMed (MA, USA), a pioneer in the field of decentralized real-world evidence studies, and the LUNGevity Foundation (MD, USA) — the leading not-for-profit lung cancer organization in the USA — have announced their collaboration to gather patient-reported outcomes from caregivers and individuals with lung cancer in real-world settings, providing novel approaches for lung cancer clinical studies. Traditional clinical investigations can often provide...